Update of a report made in 2011, with surveillance data for the 2013 year and updated estimates.
Quantifying the reduction of Campylobacter jejuni on skin-on chicken breast portions frozen and stored for up to 10 weeks at -12oC
NZFSA has a performance goal for human campylobacteriosis of a 50% reduction in
foodborne component after a period of five years. To achieve this, a Campylobacter Risk
Management Strategy has been put in place. To inform both the risk management and risk
communication activities of the Strategy, information on the knowledge, attitudes and beliefs with respect to Campylobacter in poultry and food-borne campylobacteriosis in humans is essential.
Evidence from disease notifications, case investigations, outbreak investigations and epidemiological studies of human enteric diseases is increasingly used as a source of data for risk assessments and source attribution. However, its application is often restricted by the strength of the evidence presented and its interpretation. Geographical variations in disease incidence have long been described in New Zealand but their aetiologies have not been identified. A range of reports have described variation in the present system of public health investigation and the management of identified cases of human enteric diseases.
A report summarising transmission routes for campylobacteriosis in New Zealand (food and environmental).